Matches in Nanopublications for { ?s ?p "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_provenance.
- NP1134370.RADZdP5ghCuBpNoJ1ZSzY9RlyBjrGuoPjzYk8Yym8hiMw130_assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134370.RADZdP5ghCuBpNoJ1ZSzY9RlyBjrGuoPjzYk8Yym8hiMw130_provenance.
- NP828078.RASwE6AKqJ0xxJsDheZRZ8vzBltM5qmjQfOOQ8WeLdpb8130_assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828078.RASwE6AKqJ0xxJsDheZRZ8vzBltM5qmjQfOOQ8WeLdpb8130_provenance.
- assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134369.RAL5RFCopfgLZXhX0sg4PduQiq8rdibN4LvIANQKxLGb4130_provenance.